Stock

GIL

Gildan Activewear Inc.

Latest close $567 of 27 marquee funds currently hold1 CUSIP mapped

Current holders

27 funds tracked

Ever held

Current + past

New this quarter

Exited this quarter

Marquee-fund ownership over time

Aug 10, 2017Aug 11, 2022Feb 14, 2025May 15, 2026

Now

This quarter's activity

New positions opened

None.

Positions exited

Bridgewater Associates
Q2 2026 · +39%
EXIT

Current holders

Sorted by tenure (longest first)

Fund	First disclosed	Held	Entry price	Latest close	Return on entry
Citadel Advisors	Q3 2024(8Q snapshot)	7Q	$41	$56	+39%
Two Sigma Investments re-entered	Q3 2024(8Q snapshot)	7Q	$41	$56	+39%
D.E. Shaw	Q3 2024(8Q snapshot)	7Q	$41	$56	+39%
Millennium Management re-entered	Q3 2024(8Q snapshot)	7Q	$41	$56	+39%
AQR Capital Management	Q4 2024(8Q snapshot)	6Q	$47	$56	+20%
Point72 Asset Management re-entered	Q1 2025(8Q snapshot)	5Q	$50	$56	+13%
Renaissance Technologies	Q1 2026(8Q snapshot)	1Q	$72	$56	-22%

“Return on entry” is the price-only move from the fund's first disclosure to today — it ignores any adds, trims, or dividends. A fund that built its position over multiple quarters has a true cost basis somewhere between entry price and latest close; this figure is the upper bound.

Past holders

Funds that exited at some point

Fund	Last entry	Exited	Entry → Exit	Return
Bridgewater Associates 3× in & out	Q3 2024	Q2 2026	→ $56	+39%
Maverick Capital 3× in & out	Q2 2023	Q4 2023	→ $33	+16%

Fundamentals

XBRL · Gildan Activewear Inc.

Not enough XBRL history to plot. Gildan Activewear Inc.hasn't tagged revenue, net income, EPS, or operating cash flow in the SEC us-gaap taxonomy with at least two fiscal-year periods — typical for SPACs / trust vehicles, pre-revenue biotechs, recent IPOs, and foreign filers reporting under IFRS.

Recent SEC filings

10-K · 10-Q · 8-K · 13D/G · proxy

The most recent material filings for Gildan Activewear Inc. — earnings, material events, ownership disclosures, proxy statements. Form 4 insider activity is shown in the panel above.

Trade history

Every open→close lifecycle across tracked funds

Fund	Open date	Close date	Open price	Close price / current	Return
Millennium Management	Q1 2026	open	$72	$56	-22%
Renaissance Technologies	Q1 2026	open	$72	$56	-22%
Two Sigma Investments	Q4 2025	open	$58	$56	-3%
Point72 Asset Management	Q3 2025	open	$56	$56	+1%
Point72 Asset Management	Q1 2025	Q2 2025	$50	$49	-3%
AQR Capital Management	Q4 2024	open	$47	$56	+20%
Bridgewater Associates	Q3 2024	Q2 2026	$40	$56	+39%
Citadel Advisors	Q3 2024	open	$41	$56	+39%
Two Sigma Investments	Q3 2024	Q3 2025	$41	$56	+38%
D.E. Shaw	Q3 2024	open	$41	$56	+39%
Millennium Management	Q3 2024	Q4 2025	$41	$58	+44%
Maverick Capital	Q2 2023	Q4 2023	$29	$33	+16%
Maverick Capital	Q1 2022	Q3 2022	$35	$30	-16%
Maverick Capital	Q3 2021	Q4 2021	$35	$39	+10%
Bridgewater Associates	Q2 2021	Q3 2022	$33	$29	-10%
Bridgewater Associates	Q3 2017	Q3 2020	$26	$17	-34%

Caveats

Covers only the 27 marquee funds tracked here, not the full institutional universe. A “0 holders” reading does not mean unowned.
Heavy funds (Renaissance Technologies, Citadel Advisors, Soros Fund Management, Two Sigma Investments, D.E. Shaw, AQR Capital Management, Millennium Management, Point72 Asset Management) use 8-quarter snapshots, so their pre-2024 history is missing.
“Current” reflects each fund's most recent 13F — filings lag the actual trade by up to 45 days; positions shown may have changed since.
Cost = price at the entry filing date. Re-entered positions show the most recent open lot.
Options, ADRs, and unmapped CUSIPs are excluded from the follower-backtest pipeline that produces these snapshots, so certain holding types won't appear here.